Trial · NCT03840902
Adverse events732
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 732
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | cCRT Plus M7824 Followed by M7824 | 38 | 74 | 49 |
| other | Anaemia | Blood and lymphatic system disorders | cCRT Plus Placebo Followed by Durvalumab | 32 | 77 | 53 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | cCRT Plus M7824 Followed by M7824 | 1 | 74 | 1 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | cCRT Plus Placebo Followed by Durvalumab | 0 | 77 | 0 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | cCRT Plus M7824 Followed by M7824 | 1 | 74 | 1 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | cCRT Plus Placebo Followed by Durvalumab | 0 | 77 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | cCRT Plus M7824 Followed by M7824 | 9 | 74 | 13 |
| other | Leukopenia | Blood and lymphatic system disorders | cCRT Plus Placebo Followed by Durvalumab | 10 | 77 | 12 |
| other | Lymphopenia | Blood and lymphatic system disorders | cCRT Plus M7824 Followed by M7824 | 4 | 74 | 4 |
| other | Lymphopenia | Blood and lymphatic system disorders | cCRT Plus Placebo Followed by Durvalumab | 3 | 77 | 3 |
| other | Neutropenia | Blood and lymphatic system disorders | cCRT Plus M7824 Followed by M7824 | 20 | 74 | 27 |
| other | Neutropenia | Blood and lymphatic system disorders | cCRT Plus Placebo Followed by Durvalumab | 15 | 77 | 18 |
| other | Pancytopenia | Blood and lymphatic system disorders | cCRT Plus M7824 Followed by M7824 | 1 | 74 | 1 |
| other | Pancytopenia | Blood and lymphatic system disorders | cCRT Plus Placebo Followed by Durvalumab | 1 | 77 | 2 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | cCRT Plus M7824 Followed by M7824 | 11 | 74 | 16 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | cCRT Plus Placebo Followed by Durvalumab | 7 | 77 | 8 |
| other | Angina pectoris | Cardiac disorders | cCRT Plus M7824 Followed by M7824 | 2 | 74 | 3 |
| other | Angina pectoris | Cardiac disorders | cCRT Plus Placebo Followed by Durvalumab | 0 | 77 | 0 |
| other | Atrial fibrillation | Cardiac disorders | cCRT Plus M7824 Followed by M7824 | 2 | 74 | 2 |
| other | Atrial fibrillation | Cardiac disorders | cCRT Plus Placebo Followed by Durvalumab | 1 | 77 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03840902/events